APA (7th ed.) Citation

LM, R., XC, Z., XY, Z., QQ, Z., QN, Z., CL, F., . . . YH, W. (2026). Real-world Effectiveness and Safety of Coblopasvir plus Sofosbuvir in the Treatment of Chronic Hepatitis C Infection in Wenzhou, Eastern China: A Multicenter Observational Study. Journal of clinical and translational hepatology, 14(3), 358. https://doi.org/10.14218/JCTH.2025.00673

Chicago Style (17th ed.) Citation

LM, Ruan, Zhang XC, Zhang XY, Zhou QQ, Zheng QN, Fu CL, Hu YB, Zhou Y, and Wu YH. "Real-world Effectiveness and Safety of Coblopasvir Plus Sofosbuvir in the Treatment of Chronic Hepatitis C Infection in Wenzhou, Eastern China: A Multicenter Observational Study." Journal of Clinical and Translational Hepatology 14, no. 3 (2026): 358. https://doi.org/10.14218/JCTH.2025.00673.

MLA (9th ed.) Citation

LM, Ruan, et al. "Real-world Effectiveness and Safety of Coblopasvir Plus Sofosbuvir in the Treatment of Chronic Hepatitis C Infection in Wenzhou, Eastern China: A Multicenter Observational Study." Journal of Clinical and Translational Hepatology, vol. 14, no. 3, 2026, p. 358, https://doi.org/10.14218/JCTH.2025.00673.